Latest Period
n/a
Security Snapshot
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) Institutional Ownership
CUSIP: G6256B106
13F Institutional Holders and Ownership History from Q2 2022 to Q2 2025
Institutions Reporting
Shares (Excl. Options)
Price
$11.54
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Class A common stock, par value $0.0001 per share
- Symbol
- DNQAF on OTC
- Shares outstanding
- 1,261,821
- Price per share
- $11.54
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share is tracked under CUSIP G6256B106.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 6 to 0 between Q1 2025 and Q2 2025.
- Reported value moved from $8,216,159 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP G6256B106?
CUSIP G6256B106 identifies DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G6256B106:
Institutional Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q2 | 0 | $0 | -$8,216,159 | $11.54 | 0 |
| 2025 Q1 | 674,890 | $8,216,159 | -$176,919 | $12.18 | 6 |
| 2024 Q4 | 689,480 | $8,162,099 | -$638,731 | $11.86 | 6 |
| 2024 Q3 | 744,672 | $8,629,313 | -$24,929,893 | $11.59 | 7 |
| 2024 Q2 | 3,015,414 | $33,611,838 | +$9,084,045 | $11.19 | 17 |
| 2024 Q1 | 1,976,890 | $21,854,701 | -$4,302,571 | $11.07 | 11 |
| 2023 Q4 | 2,417,115 | $25,660,875 | -$66,082,155 | $10.17 | 16 |
| 2023 Q3 | 8,482,878 | $92,728,284 | +$3,069,705 | $10.95 | 32 |
| 2023 Q2 | 8,225,191 | $88,051,082 | +$2,574,500 | $10.71 | 34 |
| 2023 Q1 | 7,971,555 | $83,347,055 | +$11,706,832 | $10.47 | 32 |
| 2022 Q4 | 6,958,359 | $71,407,231 | -$1,229,240 | $10.29 | 28 |
| 2022 Q3 | 7,081,266 | $71,227,000 | +$27,023,145 | $10.07 | 29 |
| 2022 Q2 | 4,389,667 | $43,544,000 | +$43,544,000 | $9.92 | 18 |